Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,600.00

Mettler-Toledo International (NYSE:MTD) had its price objective lifted by Stifel Nicolaus from $1,400.00 to $1,600.00 in a report issued on Monday,Benzinga reports. The firm currently has a buy rating on the medical instruments supplier’s stock.

A number of other brokerages have also commented on MTD. Jefferies Financial Group raised their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Citigroup dropped their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Barclays upped their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the company an “overweight” rating in a research note on Monday. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $1,461.27.

Mettler-Toledo International Trading Down 1.2%

NYSE MTD opened at $1,420.36 on Monday. The firm’s 50 day moving average price is $1,257.36 and its two-hundred day moving average price is $1,273.39. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. Mettler-Toledo International has a twelve month low of $1,023.05 and a twelve month high of $1,525.17. The stock has a market cap of $28.46 billion, a price-to-earnings ratio of 31.97, a PEG ratio of 2.95 and a beta of 1.23.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company earned $10.09 earnings per share. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Equities analysts anticipate that Mettler-Toledo International will post 47.37 EPS for the current year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Thomas P. Salice sold 415 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,444.62, for a total value of $599,517.30. Following the transaction, the director directly owned 292 shares of the company’s stock, valued at $421,829.04. This represents a 58.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shawn Vadala sold 2,240 shares of the firm’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the sale, the chief financial officer directly owned 5,579 shares of the company’s stock, valued at $7,989,128. This trade represents a 28.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,895 shares of company stock valued at $4,149,711 in the last three months. Insiders own 0.71% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Tema ETFs LLC lifted its stake in Mettler-Toledo International by 8.8% in the second quarter. Tema ETFs LLC now owns 347 shares of the medical instruments supplier’s stock valued at $443,000 after acquiring an additional 28 shares during the last quarter. Handelsbanken Fonder AB increased its stake in shares of Mettler-Toledo International by 11.4% during the 2nd quarter. Handelsbanken Fonder AB now owns 14,165 shares of the medical instruments supplier’s stock worth $18,096,000 after purchasing an additional 1,446 shares during the last quarter. Sax Wealth Advisors LLC raised its holdings in shares of Mettler-Toledo International by 56.0% during the 2nd quarter. Sax Wealth Advisors LLC now owns 426 shares of the medical instruments supplier’s stock valued at $538,000 after purchasing an additional 153 shares in the last quarter. Czech National Bank raised its holdings in shares of Mettler-Toledo International by 3.9% during the 2nd quarter. Czech National Bank now owns 5,752 shares of the medical instruments supplier’s stock valued at $7,348,000 after purchasing an additional 217 shares in the last quarter. Finally, PensionDanmark Pensionsforsikringsaktieselskab lifted its stake in shares of Mettler-Toledo International by 27.4% in the 2nd quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 7,342 shares of the medical instruments supplier’s stock valued at $9,379,000 after purchasing an additional 1,577 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International News Summary

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Analyst price-target increases: Stifel Nicolaus raised its price target to $1,600, while Wells Fargo lifted its target to $1,450. Barclays also indicated that the stock is expected to rise, supporting the view that analysts see additional upside. Stifel Nicolaus Increases Mettler-Toledo International Price Target Wells Fargo Boosts Mettler-Toledo International Price Target Barclays Analyst Expects Mettler-Toledo Stock to Rise
• Positive Sentiment: Morgan Stanley raised its target: Morgan Stanley increased its target from $1,275 to $1,450, although it maintained an “equal weight” rating, signaling limited conviction relative to a bullish recommendation. Morgan Stanley Raises Mettler-Toledo Price Target
• Positive Sentiment: Institutional buying: Baron Capital added to its MTD position following a sharp decline, suggesting at least one investment manager viewed the weakness as an opportunity. Baron Capital Added to Mettler-Toledo
• Negative Sentiment: Multiple insider sales: CFO Shawn Vadala sold 2,240 shares for approximately $3.21 million, reducing his holdings by 28.65%. Director Thomas P. Salice sold 415 shares worth about $599,500, while insider Gerry Keller sold 240 shares worth roughly $342,500. The transactions reduce insider ownership and may weigh on sentiment, although the filings do not establish the reasons for the sales.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.